With Air Canada seeking to acquire Air Transat, many public figures have made comments to the effect that this consolidation would lead to price increases. This argument is based on the premise that competition in a given market is determined by the size and the number of firms that are active in that market.

The Securities and Exchange Commission could end up killing the public markets it is supposed to protect.

The Securities and Exchange Commission could end up killing the public markets it is supposed to protect.

May 16, 2019 | 10 min. 35 sec. | Le retour d’Éric Duhaime (FM 93) Interview (in French) with Vincent Geloso, Associate […]

The sharing economy and our current employment laws.

The economic cost of solutions to the challenges posed by flood-plain dwellers.

Health Canada’s reform of the pricing mechanism for new drugs could delay their introduction.

Interview (in French) with Mathieu Bédard, Economist at the MEI, about Health Canada’s reform of the pricing mechanism for new drugs and how it could delay their introduction. Broadcast on April 18, 2019, on the LCN Mario Dumont show.

Health Canada’s reform of the pricing mechanism for new drugs could delay their introduction.

The Canadian government is planning to change the way prices are set for new patented drugs and cut the maximum prices at which these drugs can be sold by up to 70%. But this reform could prove very costly for patients. If it goes forward and fails to take into account the adverse effects of reference pricing systems, which have been well documented by various international bodies, Canadians could see their access to new drugs slowed down or even compromised.